Diabetes Injection Pens Market By Indication (Type I Diabetes, Type Ii Diabetes), By Product Type (Insulin Pens, Insulin Pen Needles), By Form (Disposable, Reusable) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

The purpose of this research study titled ‘Diabetes Injection Pens Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global diabetes injection pens market. This report presents and analyzes the major trends prevalent in the global diabetes injection pens market and the market size and forecast.

This report categorizes the global diabetes injection pens market in terms of Diabetes type, product type, form and geographical distribution. Based on diabetes type, the global diabetes injection pens market is categorized into type I and type II diabetes. Insulin pens and insulin pen needles are the major product types considered in this study. Furthermore, disposable and reusable forms of diabetes injection pens are also studies in this report. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global diabetes injection pens market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • EU 7
    • CIS
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of diabetes type, product type, form, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global diabetes injection pens market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the diabetes injection pens market. The key players profiled in this report are AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen Mumford Ltd. and Wockhardt Ltd.

Choose License Type
Published Date:  May 2017
Category:  Medical Devices
Report ID:   58476
Report Format:   PDF
Pages:   120
Rating:    4.3 (65)
Connect With Us
24/7 Research Support